Hematology

Multiple myeloma (MM) is a B cell malignancy characterised by abnormal proliferation of plasma cells that expand in the bone marrow…

In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…

The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…

CTCL is a rare type of non-Hodgkin lymphoma, primarily presenting in the skin but with extracutaneous involvement in some patients. Around…

Recent efforts to incorporate genome editing into CAR T cell therapy offers novel opportunities for treatment of haematologic malignancies…

Ajay Kakkar opened this virtual meeting by discussing the history of the treatment and prevention of thrombosis…

Rachel Kesse-Adu highlighted that the hallmark of sickle cell disease (SCD) is painful vaso-occlusive crises (VOCs). These not only cause…

In recent years, there has been an increasing appreciation of the role that patient characteristics such as age, gender…